Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trial
Clinical trial NCT07030621 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07030621
- Sponsor
- RenJi Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2027-07-31
- Enrollment
- 436
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.